Jonathan Milner
Founder at Axol Bioscience Ltd.
Net worth: 212 M $ as of 2022-12-30
Profile
Jonathan Simon Milner is the founder of Abcam Plc, which was founded in 1998.
He held the position of Non-Executive Deputy Chairman from 2014 to 2020.
He is also the founder of Axol Bioscience Ltd., which was founded in 2013, where he currently holds the position of Chairman.
In addition to his founding positions, Dr. Milner currently holds several other roles.
Since 2013, he has been the Chairman of Cambridge Allergy Ltd.
He is also a Director at Camgene Ltd., AbShare Share Plan Ltd., The Evolution Education Trust, Meltwind Ltd., and The Natural History Museum Development Trust.
Since 2015, he has been a Director at PhoreMost Ltd.
and a Non-Executive Director at Healx Ltd.
He became a Non-Executive Director at Syndicate Room Group Ltd.
in 2015.
In 2017, he became a Director at Avocet 66 Ltd., Peregrine 66 Ltd., and Suntail 66 Ltd.
In 2019, he became a Director at Start Codon Ltd.
He also serves as an Advisor at Cambridge Innovation Capital Ltd and is a Member of Meltwind Advisory LLP.
Dr. Milner has held former positions as well.
He was the Chairman of Sensiia Ltd.
and DefiniGEN Ltd.
He served as a Non-Executive Director at Horizon Discovery Ltd., Frontier Developments Plc, GeoSpock Ltd., Horizon Discovery Group Ltd., and Repositive Ltd.Dr. Milner's education includes an undergraduate degree from the University of Bath and a doctorate degree from the University of Leicester.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ABCAM PLC
6.19% | 2023-10-31 | 14,182,902 ( 6.19% ) | 212 M $ | 2022-12-30 |
Jonathan Milner active positions
Companies | Position | Start |
---|---|---|
Camgene Ltd. | Director/Board Member | - |
AbShare Share Plan Ltd. | Director/Board Member | - |
The Evolution Education Trust | Director/Board Member | - |
Meltwind Ltd. | Director/Board Member | - |
The Natural History Museum Development Trust | Director/Board Member | - |
Axol Bioscience Ltd.
Axol Bioscience Ltd. BiotechnologyHealth Technology Axol Bioscience Ltd. is a biotech company that develops and produces induced pluripotent stem cell-derived clinically relevant cells for use in biomedical research and discovery. Its products include human neural progenitor cells, young frozen human cerebral cortical neurons, plated human cerebral cortical neurons, Alzheimer's disease human neural progenitor cells, reagents, and lipid-based transfection reagents. The firm's products are used in the testing of new drug compounds, as well as in the development of therapies for various diseases, such as Alzheimer’s. The company was founded by Yichen Shi and Jonathan Simon Milne and is headquartered in Cambridge, the United Kingdom. | Founder | 2013-01-31 |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Syndicate Room Group Ltd. | Director/Board Member | 2015-08-31 |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Chairman | 2012-12-31 |
░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Former positions of Jonathan Milner
Companies | Position | End |
---|---|---|
░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Jonathan Milner
University of Bath | Undergraduate Degree |
University of Leicester | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ABCAM PLC | Health Technology |
FRONTIER DEVELOPMENTS PLC | Consumer Durables |
Private companies | 22 |
---|---|
Sensiia Ltd.
Sensiia Ltd. Electronic Equipment/InstrumentsElectronic Technology Sensiia Ltd. develops consumer telemedicine solutions. Its flagship product, DuoFertility is a stick-on sensor and handheld reader device that tracks specific biometrics like temperature to help women conceive. The firms services combine wearable monitoring that continuously tracks multiple elements of physiological measurement, scientific and medically based data analytics and specialist advisers to provide personalized, positive health outcomes in areas that affect including fertility, sleep disturbance and pain. The company was founded by Shamus Louis Godfrey Husheer, David Naumann, Oriane Elisabeth Chausiaux, Lydia Ferguson, Chafic Ayoub and Scott Robert Mackie in 2006 and is headquartered in Cambridge, the United Kingdom. | Electronic Technology |
Camgene Ltd. | |
AbShare Share Plan Ltd. | |
The Evolution Education Trust | |
Meltwind Ltd. | |
The Natural History Museum Development Trust | |
Axol Bioscience Ltd.
Axol Bioscience Ltd. BiotechnologyHealth Technology Axol Bioscience Ltd. is a biotech company that develops and produces induced pluripotent stem cell-derived clinically relevant cells for use in biomedical research and discovery. Its products include human neural progenitor cells, young frozen human cerebral cortical neurons, plated human cerebral cortical neurons, Alzheimer's disease human neural progenitor cells, reagents, and lipid-based transfection reagents. The firm's products are used in the testing of new drug compounds, as well as in the development of therapies for various diseases, such as Alzheimer’s. The company was founded by Yichen Shi and Jonathan Simon Milne and is headquartered in Cambridge, the United Kingdom. | Health Technology |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
GeoSpock Ltd.
GeoSpock Ltd. Data Processing ServicesTechnology Services GeoSpock Ltd. provides data software products. It offers illumin, extrapol and cogn8 products. The company was founded by Steven Marsh and Darrin Mathew Disley in 2013 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
Horizon Discovery Group Ltd.
Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Finance |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Repositive Ltd.
Repositive Ltd. Internet Software/ServicesTechnology Services Repositive Ltd. engages in developing a platform for facilitating access to and sharing of human genomic data. The company platform includes features for discovery of available data, making users data visible to the research community, managing users data sources, and initiating data collaborations. Its platform also integrates methods for secure data sharing and a mechanism for secure privacy-preserving data access. The company was founded by Fiona Nielsen and Adrian Alexa in August 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
Syndicate Room Group Ltd. | |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Meltwind Advisory LLP | |
Avocet 66 Ltd.
Avocet 66 Ltd. Financial ConglomeratesFinance Avocet 66 Ltd. is a British financial intermediary company founded in 2017. | Finance |
Peregrine 66 Ltd.
Peregrine 66 Ltd. Financial ConglomeratesFinance Peregrine 66 Ltd. is a British investment services company founded in 2017. The private company is based in London, UK. The company provides investment services. | Finance |
Suntail 66 Ltd.
Suntail 66 Ltd. Financial ConglomeratesFinance Suntail 66 Ltd. provides financial intermediary services. The private company is based in London, UK. | Finance |
Start Codon Ltd.
Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Finance |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Jonathan Milner